Co-Authors
This is a "connection" page, showing publications co-authored by Roberto Vettor and Raffaele Pesavento.
Connection Strength
1.699
-
The hazard of (sub)therapeutic doses of anticoagulants in non-critically ill patients with Covid-19: The Padua province experience. J Thromb Haemost. 2020 Oct; 18(10):2629-2635.
Score: 0.899
-
Cardiac injury and mortality in patients with Coronavirus disease 2019 (COVID-19): insights from a mediation analysis. Intern Emerg Med. 2021 Mar; 16(2):419-427.
Score: 0.226
-
Arrhythmic profile and 24-hour QT interval variability in COVID-19 patients treated with hydroxychloroquine and azithromycin. Int J Cardiol. 2020 10 01; 316:280-284.
Score: 0.221
-
Correction to: Use of low-molecular weight heparin, transfusion and mortality in COVID-19 patients not requiring ventilation. J Thromb Thrombolysis. 2021 Oct; 52(3):980.
Score: 0.061
-
Disentangling the Association of Hydroxychloroquine Treatment with Mortality in Covid-19 Hospitalized Patients through Hierarchical Clustering. J Healthc Eng. 2021; 2021:5556207.
Score: 0.060
-
Use of low-molecular weight heparin, transfusion and mortality in COVID-19 patients not requiring ventilation. J Thromb Thrombolysis. 2021 Oct; 52(3):772-778.
Score: 0.059
-
Lung Ultrasound Patterns and Clinical-Laboratory Correlates during COVID-19 Pneumonia: A Retrospective Study from North East Italy. J Clin Med. 2021 Mar 20; 10(6).
Score: 0.058
-
Mortality and Transfusion Requirements in COVID-19 Hospitalized Italian Patients According to Severity of the Disease. J Clin Med. 2021 Jan 11; 10(2).
Score: 0.058
-
Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST Study. Thromb Haemost. 2021 Aug; 121(8):1054-1065.
Score: 0.058